Skip to main content

Animations

MJFF Publications

1951 - 1960 of 9034 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2024
  • 2024
  • 2023
  • 2024
  • 2024
  • 2023
  • 2024
  • Summary Details
    OPEN
    Title: Analysis of Y chromosome haplogroups in Parkinson’s disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcac277
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1136/jnnp-2021-327376
    Citation Count: 11
  • Summary Details
    OPEN
    Title: The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.cell.2022.05.008
    Citation Count: 161
  • Summary Details
    OPEN
    Title: AI-based differential diagnosis of dementia etiologies on multimodal data
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-024-03118-z
    Citation Count: 143
  • Summary Details
    OPEN
    Title: CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-52298-2
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Inhibition of striatal dopamine release by the L‐type calcium channel inhibitor isradipine co‐varies with risk factors for Parkinson's
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.16180
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Gene-Specific Effects on Brain Volume and Cognition of TMEM106B in Frontotemporal Lobar Degeneration
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000209832
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Temporal evolution of microstructural integrity in cerebellar peduncles in Parkinson’s disease: Stage-specific patterns and dopaminergic correlates
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nicl.2024.103679
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Parallel neurodegenerative phenotypes in sporadic Parkinson’s disease fibroblasts and midbrain dopamine neurons
    Journal Name: Progress in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.pneurobio.2023.102501
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Detection of mosaic and population-level structural variants with Sniffles2
    Journal Name: Nature Biotechnology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41587-023-02024-y
    Citation Count: 410
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.